Edap TMS (Edap TMS) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Edap TMS Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Edap TMS's Capital Expenditure for the three months ended in Dec. 2023 was $-0.87 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-3.80 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Edap TMS Capex-to-Operating-Income Historical Data

The historical data trend for Edap TMS's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS Capex-to-Operating-Income Chart

Edap TMS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Operating-Income

Get a 7-Day Free Trial

0.66

7.34

Edap TMS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Edap TMS's Capex-to-Operating-Income

For the Medical Distribution subindustry, Edap TMS's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Edap TMS's Capex-to-Operating-Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Edap TMS's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Edap TMS's Capex-to-Operating-Income falls into.

Edap TMS Capex-to-Operating-Income Calculation

Edap TMS's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-4.685)	/	-21.605
	=	N/A

Edap TMS's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.868)	/	-3.795
	=	N/A

Edap TMS (NAS:EDAP) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Edap TMS Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Edap TMS's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Edap TMS (Edap TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

EDA:Germany

Address

Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120

Website

https://www.edap-tms.com

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.